Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Small

Showing results (741-750 of 1,325) with videos related to

Pageof 133
Sort By:
Cancer Research|June 11, 1999
Selection for androgen receptor mutations in prostate cancers treated with androgen antagonistM E Taplin, G J Bubley, Y J Ko, et al.
Australian and New Zealand Journal of Medicine|April 14, 1999
Familial risk estimation in systemic sclerosisH Englert, J Small-McMahon, P Chambers, et al.
Endocrinology|April 4, 2000
Characterization of human and rat glucagon-like peptide-1 receptors in the neurointermediate lobe: lack of coupling to either stimulation or inhibition of adenylyl cyclaseF Satoh, S A Beak, C J Small, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2003
Single-cell nonphotochemical hole burning of ovarian surface epithelial carcinoma and normal cellsR J Walsh, S Matsuzaki, T Reinot, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1997
Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic studyK Meeran, D O'Shea, P D Upton, et al.
Investigational New Drugs|April 27, 2007
Phase I dose escalation and pharmacokinetic study of AZD2171, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinase, in patients with hormone refractory prostate cancer (HRPC)Charles J Ryan, Walter M Stadler, Bruce Roth, et al.
International Journal of Obesity (2005)|April 19, 2006
Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trialK Wynne, A J Park, C J Small, et al.
The Journal of Arthroplasty|July 31, 2014
Primary total knee arthroplasty allogenic transfusion trends, length of stay, and complications: nationwide inpatient sample 2000-2009Alison K Klika, Travis J Small, Anas Saleh, et al.
Genetic Testing and Molecular Biomarkers|November 26, 2009
A pilot study of hereditary breast and ovarian knowledge among a multiethnic group of Hispanic women with a personal or family history of cancerSusan T Vadaparampil, Gwendolyn P Quinn, Brent J Small, et al.
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences|October 30, 2025
Associations between pain reactivity to worse sleep and health outcomesChristina X Mu, Brent J Small, Christina S McCrae, et al.
Pageof 133

Showing results (741-750 of 1,325) with videos related to

Sort By:
Pageof 133
Cancer Research|June 11, 1999
Selection for androgen receptor mutations in prostate cancers treated with androgen antagonistM E Taplin, G J Bubley, Y J Ko, et al.
Australian and New Zealand Journal of Medicine|April 14, 1999
Familial risk estimation in systemic sclerosisH Englert, J Small-McMahon, P Chambers, et al.
Endocrinology|April 4, 2000
Characterization of human and rat glucagon-like peptide-1 receptors in the neurointermediate lobe: lack of coupling to either stimulation or inhibition of adenylyl cyclaseF Satoh, S A Beak, C J Small, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2003
Single-cell nonphotochemical hole burning of ovarian surface epithelial carcinoma and normal cellsR J Walsh, S Matsuzaki, T Reinot, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1997
Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic studyK Meeran, D O'Shea, P D Upton, et al.
Investigational New Drugs|April 27, 2007
Phase I dose escalation and pharmacokinetic study of AZD2171, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinase, in patients with hormone refractory prostate cancer (HRPC)Charles J Ryan, Walter M Stadler, Bruce Roth, et al.
International Journal of Obesity (2005)|April 19, 2006
Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trialK Wynne, A J Park, C J Small, et al.
The Journal of Arthroplasty|July 31, 2014
Primary total knee arthroplasty allogenic transfusion trends, length of stay, and complications: nationwide inpatient sample 2000-2009Alison K Klika, Travis J Small, Anas Saleh, et al.
Genetic Testing and Molecular Biomarkers|November 26, 2009
A pilot study of hereditary breast and ovarian knowledge among a multiethnic group of Hispanic women with a personal or family history of cancerSusan T Vadaparampil, Gwendolyn P Quinn, Brent J Small, et al.
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences|October 30, 2025
Associations between pain reactivity to worse sleep and health outcomesChristina X Mu, Brent J Small, Christina S McCrae, et al.
Pageof 133